dalteparin has been researched along with darexaban in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Funatsu, T; Iwatsuki, Y; Kaku, S; Kawasaki, T; Moritani, Y; Sato, T; Shigenaga, T; Suzuki, M | 1 |
Fuji, T; Nakamura, M; Takeuchi, M | 1 |
Agnelli, G; Eriksson, BI; Gallus, AS; Kashiwa, M; Lassen, MR; Prins, MH; Renfurm, RW; Turpie, AG | 1 |
2 trial(s) available for dalteparin and darexaban
Article | Year |
---|---|
Darexaban for the prevention of venous thromboembolism in Asian patients undergoing orthopedic surgery: results from 2 randomized, placebo-controlled, double-blind studies.
Topics: Adult; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Asian People; Azepines; Benzamides; Double-Blind Method; Drug Administration Schedule; Enoxaparin; Female; Humans; Male; Orthopedic Procedures; Risk Assessment; Risk Factors; Venous Thromboembolism; Young Adult | 2014 |
Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3).
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Australia; Azepines; Benzamides; Brazil; Canada; Double-Blind Method; Drug Administration Schedule; Elective Surgical Procedures; Enoxaparin; Europe; Female; Hemorrhage; Humans; India; Israel; Logistic Models; Male; Middle Aged; Odds Ratio; Phlebography; Risk Factors; South Africa; Time Factors; Treatment Outcome; United States; Venous Thromboembolism | 2014 |
1 other study(ies) available for dalteparin and darexaban
Article | Year |
---|---|
Biochemical and pharmacological profile of darexaban, an oral direct factor Xa inhibitor.
Topics: Administration, Oral; Animals; Anticoagulants; Azepines; Benzamides; Bleeding Time; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Enoxaparin; Factor Xa Inhibitors; Glucuronides; Humans; Macaca fascicularis; Male; Mice; Mice, Inbred ICR; Prothrombin Time; Rabbits; Rats; Rats, Sprague-Dawley; Thrombosis; Venous Thrombosis; Warfarin | 2011 |